350
report
Innovative Finance Models for Global Early Warning Systems for Pandemics
Despite lessons learned from COVID-19 and other outbreaks, the world remains ill-prepared for the n
ext pandemic.
+ Read More
report
Mapping the Journey: Building a Mutual Understanding for Health Equity in Clinical Research
If the objective of biomedical research is to spur innovation to create healthier communities, exte
nd life, and more effectively treat or cure disease, then persistent inequities run counter to that goal and create unnecessary barriers to health and wel
+ Read More
report
Recommendations to Advance Telehealth during and after the COVID-19 Pandemic
The use of telehealth services has expanded dramatically since the onset of COVID-19, driven by nec
essity and enabled by emergency changes to the policy landscape.
+ Read More
report
University-Foundation Relations: From Transactional to Transformative Partnerships
In biomedical research, both nonprofit disease foundations and academic research institutions are c
ommitted to translating research into effective therapies for patients.
+ Read More
report
Toward a National Action Plan for Achieving Diversity in Clinical Trials
Participation in clinical research among racial and ethnic minorities remains low, even though such
groups now represent nearly 40 percent of the US population.
+ Read More
report
COVID-19 Silver Linings for Biomedical Innovation: Implementation Roadmap
While the response to the COVID-19 pandemic has exposed many of the fault lines in the biomedical i
nnovation ecosystem that have slowed progress for decades, we have also shown ourselves capable of innovating in ways we perhaps did not think possible.
+ Read More
report
Achieving Health Equity: A Multi-Stakeholder Action Plan to Address Diversity across the Clinical Trials Enterprise and the Biomedical Research Ecosystem
Clinical trials have been used for decades as the primary way by which researchers determine if a n
ew treatment is safe and effective for human use.
+ Read More
panel
Part 1: A Conversation with FDA Commissioner Stephen Hahn | Part 2: Health Innovation: Improving Patient Access and Information
This session will open with a conversation with Stephen Hahn, Commissioner, US Food and Drug Adm
inistration, followed by a panel discussion.
+ Read More
report
Landscape of Trust: Health Data Frameworks
The rapid advancement of the health technology landscape relies heavily on patient data.
report
Cornerstones of Collaboration: Foundation-Led Partnerships to Accelerate R&D
Multi-stakeholder collaboration isn’t just the participation trophy of biomedical research and deve
lopment (R&D), a nice way to make sure everyone feels included.
+ Read More
panel
Part 1: A Conversation with Rep. Anna Eshoo | Part 2: Unseen Burdens: Managing Chronic Disease During COVID-19 and Beyond
This session will begin with a conversation with US Representative, California, Anna Eshoo follo
wed by a panel discussion.
+ Read More
video
A Conversation with Scott Gottlieb, Commissioner, U.S. Food and Drug Administration
This closing session will begin with a conversation with Scott Gottlieb, Commissioner, U.S. Food a
nd Drug Administration, moderated by FasterCures' Tanisha Carino.
+ Read More